Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
GE HealthCare
GEHC
|
+$554M |
| 2 |
Microsoft
MSFT
|
+$470M |
| 3 |
Apple
AAPL
|
+$398M |
| 4 |
Amazon
AMZN
|
+$389M |
| 5 |
Merck
MRK
|
+$306M |
Top Sells
| 1 |
GE Aerospace
GE
|
+$477M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$288M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
Philip Morris
PM
|
+$240M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$228M |
Sector Composition
| 1 | Technology | 26.15% |
| 2 | Healthcare | 13.96% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XXII
2901
22nd Century Group
XXII
$6.81M
| $2.76M | ﹤0.01% |
5
| – | – |
|
2902
Nautilus Biotechnolgy
NAUT
$91M
| $2.75M | ﹤0.01% |
993,686
+32,818
| +3% | +$90.9K |
|
|
WE
2903
DELISTED
WeWork Inc.
WE
| $2.75M | ﹤0.01% |
88,477
+3,023
| +4% | +$94K |
|
2904
First Western Financial
MYFW
$228M
| $2.75M | ﹤0.01% |
138,840
+372
| +0.3% | +$7.37K |
|
2905
FTAI Infrastructure
FIP
$518M
| $2.74M | ﹤0.01% |
913,623
+39,585
| +5% | +$119K |
|
2906
HF Foods Group
HFFG
$177M
| $2.72M | ﹤0.01% |
694,793
+55,590
| +9% | +$218K |
|
|
IGMS
2907
DELISTED
IGM Biosciences
IGMS
| $2.72M | ﹤0.01% |
198,057
+4,307
| +2% | +$59.2K |
|
|
MAGN
2908
Magnera Corporation
MAGN
$393M
| $2.71M | ﹤0.01% |
65,241
+1,541
| +2% | +$63.9K |
|
2909
NACCO Industries
NC
$297M
| $2.69M | ﹤0.01% |
74,711
+4,801
| +7% | +$173K |
|
2910
Northrim BanCorp
NRIM
$504M
| $2.69M | ﹤0.01% |
57,038
| – | – |
|
2911
Tilray
TLRY
$1.25B
| $2.68M | ﹤0.01% |
920,697
-14,520
| -2% | -$42.3K |
|
|
NXDR
2912
Nextdoor Holdings
NXDR
$805M
| $2.67M | ﹤0.01% |
1,243,712
+62,356
| +5% | +$134K |
|
2913
Entrada Therapeutics
TRDA
$201M
| $2.66M | ﹤0.01% |
183,790
+1,833
| +1% | +$26.6K |
|
2914
Asure Software
ASUR
$215M
| $2.66M | ﹤0.01% |
183,669
+10,865
| +6% | +$158K |
|
2915
Holley
HLLY
$370M
| $2.65M | ﹤0.01% |
968,393
+65,230
| +7% | +$179K |
|
2916
C4 Therapeutics
CCCC
$189M
| $2.64M | ﹤0.01% |
840,778
+43,486
| +5% | +$137K |
|
|
AKYA
2917
DELISTED
Akoya BioSciences
AKYA
| $2.63M | ﹤0.01% |
322,039
+14,904
| +5% | +$122K |
|
2918
ARS Pharmaceuticals
SPRY
$991M
| $2.63M | ﹤0.01% |
403,604
+71,408
| +21% | +$465K |
|
2919
Amneal Pharmaceuticals
AMRX
$3.14B
| $2.61M | ﹤0.01% |
1,875,723
+45,625
| +2% | +$63.4K |
|
2920
Telos
TLS
$490M
| $2.61M | ﹤0.01% |
1,029,730
+51,485
| +5% | +$130K |
|
2921
Weave Communications
WEAV
$591M
| $2.6M | ﹤0.01% |
523,719
+16,701
| +3% | +$83K |
|
2922
Algoma Steel
ASTL
$484M
| $2.6M | ﹤0.01% |
260,977
+129,943
| +99% | +$1.3M |
|
2923
Atlanticus Holdings
ATLC
$1.09B
| $2.59M | ﹤0.01% |
95,397
+1,317
| +1% | +$35.7K |
|
2924
Soho House & Co
SHCO
$1.73B
| $2.59M | ﹤0.01% |
395,428
+6,787
| +2% | +$44.4K |
|
|
LBC
2925
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $2.58M | ﹤0.01% |
271,783
+7,641
| +3% | +$72.4K |
|